Evaluation of Axillary Staging in Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prognostic Study Comparing Pathological Node Staging and Lymph Node Ratio Metrics in a Series of 169 Cases - Top-Institutions - MDSpire

Evaluation of Axillary Staging in Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prognostic Study Comparing Pathological Node Staging and Lymph Node Ratio Metrics in a Series of 169 Cases

  • By

  • Amin Safavi

  • Narjes Mohammadzadeh

  • Ahmad Kaviani

  • Anita Dadashi

  • Atousa Dadashi

  • January 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Surgical Oncology
    • Pathology
    • Medical Oncology

  • #2

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Breast Surgical Oncology
    • Pathology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Surgical Oncology
    • Medical Oncology
    • Pathology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Breast Surgical Oncology
    • Pathology
    • Medical Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Surgical Oncology
    • Medical Oncology
    • Pathology

Original Source(s)

Evaluation of Axillary Staging in Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prognostic Study Comparing Pathological Node Staging and Lymph Node Ratio Metrics in a Series of 169 Cases

  • by Amin Safavi, Narjes Mohammadzadeh, Ahmad Kaviani, Anita Dadashi, Atousa Dadashi

  • January 30, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women